Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7039-7043

  Dahmen, R P ^a   Koch, A ^a   Denkhaus, D ^a   Wiestler, O D ^a   Pietsch, T ^a   Tonn, J C ^b   Sorensen N ^c   Berthold, F ^d   Behrens, J ^e   Birchmeier, W ^f  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; WNT PROTEIN;

ADULT; ARTICLE; BASAL CELL NEVUS SYNDROME; CANCER INCIDENCE; CELL LINE; CHILD; COMPLEX FORMATION; EXON; FEMALE; GENE DELETION; GENETIC ANALYSIS; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; TURCOT SYNDROME;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DELETION; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; MALE; MEDULLOBLASTOMA; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0035477364     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Descriptive epidemiology of primary central nervous system tumours in children: A population-based study
2. The molecular basis of Turcot's syndrome
3. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin
4. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
5. Down-regulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β
6. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin
7. GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with Axin
8. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin
9. Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription
10. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3β and β-catenin and inhibits axis formation of Xenopus embryos
11. Domains of axin involved in protein-protein interactions. Wnt pathway inhibition, and intracellular localization
12. Regulation of glycogen synthase kinase 3β and downstream Wnt signaling by axin
13. Xenopus axin interacts with glycogen synthase kinase-3 β and is expressed in the anterior midbrain
14. Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain
15. Protein phosphatase 2Cα dephosphorylates axin and activates LEF-1- dependent transcription
16. The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila
17. A possible role for the high mobility group box transcription factor Tcf-4 in vertebrate gut epithelial cell differentiation
18. 2+ pathways
19. Wnt signalling in mammalian development and cancer
20. Sporadic medulloblastomas contain oncogenic β-catenin mutations
21. Nuclear localization and mutation of β-catenin in medulloblastomas
22. APC mutations in sporadic medulloblastomas
23. β-catenin signaling and cancer
24. Somatic mutations of WNT/WINGLESS signaling pathway components in primitive neuroectodermal tumors
25. The mouse fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation
26. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
27. DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate β-catenin stability
28. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3β-dependent phosphorylation of β-catenin and down-regulates β-catenin
29. β-catenin is a target for the ubiquitin-proteasome pathway
30. Functional domains of axin. Importance of the C terminus as an oligomerization domain
31. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system
32. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas
33. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE
34. Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding
35. Identification of novel polymorphisms in the AXIN1 and CDX-2 genes
36. Down-regulation of β-catenin by the colorectal tumor suppressor APC requires association with Axin and β-catenin
37. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC
38. Wnt signaling: A common theme in animal development
39. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling
40. Stabilization of β-catenin by genetic defects in melanoma cell lines
41. Constitutive activation of the Wnt signaling pathway by CTNNB1 (β-catenin) mutations in a subset of human lung adenocarcinoma
42. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched